Oasmia Pharmaceutical AB Share Issue Related Cost
Oasmia Pharmaceutical AB reported Share Issue Related Cost of SEK 15.50 million for the 12-month period ending 2018-04-30, per its 20-F filed 2018-09-14.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ShareIssueRelatedCost · last filed 2018-09-14
| Period end | Share Issue Related Cost 12 month |
|---|---|
| 2018-04-30 | 15.50M SEK 20-F · filed 2018-09-14 |
| 2017-04-30 | 3.60M SEK 20-F · filed 2018-09-14 |